Intacoxia MR 60mg/4mg Tablet is a combination medication containing Etoricoxib 60mg and Thiocolchicoside 4mg, formulated for the management of musculoskeletal pain and inflammation. Etoricoxib is a selective cyclooxygenase-2 (COX-2) inhibitor that provides effective anti-inflammatory and analgesic effects by reducing prostaglandin synthesis, thereby alleviating pain and swelling associated with conditions such as osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis. Thiocolchicoside is a muscle relaxant with anti-inflammatory properties that acts on glycine and GABA receptors, helping to relieve muscle spasms and stiffness commonly seen in musculoskeletal disorders. The combination of these two agents in Intacoxia MR offers dual therapeutic benefits by addressing both inflammation and muscle spasticity, enhancing patient comfort and mobility. This medication is typically prescribed for short-term use under medical supervision, with dosage tailored to the severity of symptoms and patient response. Caution is advised in patients with a history of cardiovascular disease, gastrointestinal disorders, or hepatic impairment. Common side effects may include gastrointestinal discomfort, dizziness, or allergic reactions. Intacoxia MR should be used as directed by a healthcare professional, and patients are advised to report any adverse effects promptly.